CMS to speed request process for new drug, device payment codes

May 02, 2019 - 03:11 PM

The Centers for Medicare & Medicaid Services will increase the number of opportunities to apply for Healthcare Common Procedure Coding System Level II codes from once per year to quarterly for new drugs and semiannually for new medical devices, the agency announced today, adding that details on the updated process will be forthcoming. Addressing the annual meeting of the Medical Device Manufacturers Association, CMS Administrator Seema Verma said, “We expect this will greatly improve the ability of innovators to accelerate through the adoption curve. On a related note, we’ve been hearing concerns that our Medicare contractors are making decisions to automatically non-cover technologies with category III [Current Procedural Terminology] codes, which are used for emerging technologies … Just this week, we posted answers to commonly asked questions about the LCD process, which explain that contractors are not authorized to make coverage determinations to automatically non-cover any item or service, and must instead follow the new LCD process for each and every local coverage decision they make.”

Related News Articles

Headline
FDA clarifies definition of 'remanufacturing' for medical devices needing maintenance
The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devices needing…
Headline
FDA webinar Oct. 31 on proposed rule for laboratory developed tests 
On Oct. 31 at 1 p.m. ET, the Food and Drug Administration will host a webinar to review its recent proposed rule for laboratory developed tests,…
Headline
FDA updates sterilization standards for medical device makers
The Food and Drug Administration the week of July 24 updated its recognized consensus standards database for medical devices to advance innovation in medical…
Headline
FDA releases transition plans for medical device enforcement, authorization after COVID-19 public health emergency
The Food and Drug Administration today released final guidance for transitioning medical device enforcement policies and emergency use authorizations…
Headline
FDA seeks input for future guidance on 3D printing at the point of care
The Food and Drug Administration Friday released a discussion paper on 3D printing of medical devices at the point of care to facilitate input from…
Headline
FDA approves first disposable duodenoscope
The Food and Drug Administration Friday cleared for marketing in the U.S. the first fully disposable duodenoscope. The EXALT Model D Single-Use Duodenoscope is…